REFERENCES
- Ghaemi SN, ed. Polypharmacy in psychiatry. Basel, Switzerland: Marcel Dekker, 2002.
- Mojtabai R, Olfson M. National trends in psychotropic medication polypharmacy in office-based psychiatry. Arch Gen Psychiatry 2010;67:26–36.
- Baandrup L, Allerup P, Nordentoft M, Lublin H, Glenthoj BY. Exploring regional variation in antipsychotic coprescribing practice: a Danish questionnaire survey. J Clin Psychiatry 2010;71:1457–64.
- Owen RR, Fischer EP, Kirchner JE, Clinical practice variations in prescribing antipsychotics for patients with schizophrenia. Am J Med Qual 2003;18:140–6.
- Sernyak MJ, Rosenheck R. Clinicians’ reasons for antipsychotic coprescribing. J Clin Psychiatry 2004;65:1597–600.
- Ghaemi SN. “All the worse for the fishes:” conceptual and historical background of polypharmacy in psychiatry. In: Ghaemi SN, ed. Polypharmacy in psychiatry. Basel, Switzerland: Marcel Dekker, 2002.
- Carpenter WT Jr. Evidence-based treatment for first-episode schizophrenia? Am J Psychiatry 2001;158:1771–3.
- Davidson M, Galderisi S, Weiser M, Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). Am J Psychiatry 2009;166:675–82.
- Essock SM, Schooler NR, Stroup TS, Effectiveness of switching from antipsychotic polypharmacy to monotherapy. Am J Psychiatry 2011;168:702–8.
- Correll CU, Rummel-Kluge C, Corves C, Kane JM, Leucht S. Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials. Schizophr Bull 2009;35:443–57.
- Zink M, Englisch S, Meyer-Lindenberg A. Polypharmacy in schizophrenia. Curr Opin Psychiatry 2010;23:103–11.
- Rush AJ, Trivedi MH, Stewart JW, Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry 2011;168:689–701.
- Ho DD, Bieniasz PD. HIV-1 at 25. Cell 2008;133:561–5.
- Andreadis EA, Tsourous GI, Marakomichelakis GE, High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension. J Hum Hypertens 2005;19: 491–6.
- Shorter E. Before Prozac: the troubled history of mood disorders in psychiatry. New York: Oxford University Press, 2009.
- Taylor DM, Smith L. Augmentation of clozapine with a second antipsychotic—a meta-analysis of randomized, placebo-controlled studies. Acta Psychiatr Scand 2009;119:419–25.
- Trivedi MH, Rush AJ, Wisniewski SR, Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006;163:28–40.
- Tobi H, Faber A, van den Berg PB, Drane JW, de Jong-van den Berg LT. Studying co-medication patterns: the impact of definitions. Pharmacoepidemiol Drug Saf 2007;16:405–11.
- Freudenreich O, Goff DC. Polypharmacy in schizophrenia: a fuzzy concept [Letter]. J Clin Psychiatry 2003;64:1132.
- Wu RR, Zhao JP, Jin H, Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial. JAMA 2008;299:185–93.
- Freudenreich O, Querques J, Kontos N. Checklist psychiatry's effect on psychiatric education [Letter]. Am J Psychiatry 2004;161:930.
- Kontos N, Freudenreich O, Querques J. Thoughtful diagnoses: not “checklist” psychiatry. Curr Psychiatry 2007;6:112.
- Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487–97.
- Velligan D, Sajatovic M, Valenstein M, Methodological challenges in psychiatric treatment adherence research. Clin Schizophr Relat Psychoses 2010;4:74–91.
- Mechanic D, Volkart EH. Stress, illness behavior, and the sick role. Am Sociol Rev 1961;26:51–8.
- Pilowsky I. The concept of abnormal illness behavior. Psychosomatics 1990;31:207–13.
- Klerman GL. Psychotropic hedonism vs. pharmacological Calvinism. Hastings Cent Rep 1972;2:1–3.
- Kontos N, Querques J, Freudenreich O. The problem of the psychopharmacologist. Acad Psychiatry 2006;30:218–26.
- Ghaemi SN. Hippocrates and Prozac: the controversy about antidepressants in bipolar disorder. Prim Psychiatry 2006;13:51–8.
- Fogel BS, Duffy J, McNamara ME, Salloway S. Skeptics and enthusiasts in neuropsychiatry. J Neuropsychiatry Clin Neurosci 1992;4:458–62.
- Kontos N. Perspective: biomedicine—menace or straw man? Reexamining the biopsychosocial argument. Acad Med 2011;86:509–15.
- Ackerknecht EH. Recurrent themes in medical thought. Sci Mon 1949;69:80–3.
- Cook HJ. Good advice and little medicine: the professional authority of early modern English physicians. J Br Stud 1994;33:1–31.
- Kontos N, Querques J, Freudenreich O. Fighting the good fight: responsibility and rationale in the confrontation of patients. Mayo Clin Proc 2012;87:63–6.
- Paterniti DA, Fancher TL, Cipri CS, Timmermans S, Heritage J, Kravitz RL. Getting to “no”: strategies primary care physicians use to deny patient requests. Arch Intern Med 2010;170:381–8.
- Bishop R. Workarounds that work. How to conquer anything that stands in your way at work. New York: McGraw-Hill, 2011.
- Scheurich N. The prescriber as moralist: values in the antidepressant debate. Perspect Biol Med 2006;49:199–208.
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text rev. Washington, DC: American Psychiatric Press, 2000.
- Kant I. Grundlegung zur Metaphysik der Sitten. Riga, 1785.
- Lesser CS, Lucey CR, Egener B, Braddock CH 3rd, Linas SL, Levinson W. A behavioral and systems view of professionalism. JAMA 2010;304:2732–7.